Skip to main content
McMaster University Menu Search

Canadian Cancer Society's Daffodil Campaign and CHCH's Interview with Mick Bhatia

Darlene Lane

Darlene Lane | Tuesday, April 10, 2018

To kick off Daffodil Month, CHCH News visited the SCC-RI to learn about research and how it is impacting patient care in Hamilton. We reflect back on that interview.

Not often are we approached to speak about our research in terms of awareness, so when the Canadian Cancer Society asked if we would be interviewed by CHCH to help launch the Daffodil City Campaign for 2018, we were more than pleased. 

Normally, when approached for an interview, we are providing commentary on a recent finding or discovery; a glimpse into a specific area of our research that we hope will, in turn, help educate the public further. This interview; however, was different. It allowed us to present our work on a collaborative level, and it reminded us of the unique position we are in, here in Hamilton. 

There is no question, our research would not be possible without agencies like the Canadian Cancer Society. But more importantly, we would not be able to help move the needle if we were not supported by the clinicians, nurses, and cancer patients who generously donate their expertise and blood samples for study. This collaborative effort makes the SCC-RI an ideal and advantageous place for performing translational leukemia studies in drug discovery and for analyzing stem cells to learn about how they change and become different cells. 

Basic scientific research is expensive and often, when a scientist is confident that he or she is on the cusp of a discovery, the cells being studied present something unexpected that requires additional investigation. Further, since our research includes human cells, cancer research is more than just finding a cure. It’s also about improving the quality of life for those affected by cancer. 

Progress made in the area of leukemia management, including creating new approaches for treating leukemia at diagnosis, at relapse, and perhaps during bone marrow transplantation, represents a transformative future for us all. 

The Bhatia Lab and the SCC-RI are proud to be part of this collaborative effort with the Hamilton Health Sciences, the Hamilton community, and patients at large… a true team approach can change cancer outcomes for the better!

Mick Bhatia

Mick Bhatia

Director and Senior Scientist